22NW Fund, LP - 23 Dec 2024 SCHEDULE 13D/A Report for Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR)

Filing Manager
22NW Fund, LP
Reporting Manager
22NW Fund, LP
Security
Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share
Symbol
LFCR
Shares outstanding
39.3M shares
Disclosed Ownership
4.37M shares
Ownership
11.1%
Form type
SCHEDULE 13D/A
Filing time
26 Dec 2024, 13:20:34 UTC
Date of event
23 Dec 2024
Next filing
29 May 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
22NW Fund, LP 11.1% 4.37M 4.37M 0 22NW Fund GP, LLC General Partner 0001640809
22NW, LP 11.1% 4.37M 4.37M 0 22NW GP, Inc., General Partner 0001694297
22NW Fund GP, LLC 11.1% 4.37M 4.37M 0 /s/ Aron R. English Manager 0001770575
22NW GP, Inc. 11.1% 4.37M 4.37M 0 /s/ Aron R. English President and Sole Shareholder 0001783663
Aron R. English 11.1% 4.37M 4.37M 0 /s/ Aron R. English Individually and as attorney-in-fact for Nathaniel Calloway 0001770436
Bryson O. Hirai-Hadley 0% 583 583 0 /s/ Bryson O. Hirai-Hadley Bryson O. Hirai-Hadley 0001888106
Nathaniel Calloway 0% 34.3K 34.3K 0 /s/ Aron R. English As attorney-in-fact for Nathaniel Calloway 0001952771